BioVentrix, Inc. is a privately held specialty medical device company headquartered in Mansfield, Massachusetts. The firm serves cardiothoracic surgeons and patients by developing lifesaving therapies for heart failure.
Subscribe to see BIOVENTRIX INC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BIOVENTRIX INC is a medical devices company headquartered in United States, founded in 2003. Its most recent funding round raised $1.2M in September 2026. Xcout tracks 10 named people at BIOVENTRIX INC, including DAVID RICHMOND (Chief Executive Officer).
4 more named people on record for BIOVENTRIX INC, with roles, board committees and tenure — see the full roster →
The 3 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $1.2M | — | |
| SEC Form D filing | $3M | — | |
| SEC Form D filing | $6.7M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of BIOVENTRIX INC's closest competitors — see the full list of competitors and alternatives →
Cardiothoracic Systems is headquartered in Natick, Massachusetts, and operates within the surgical devices industry. The company designs, develops, and manufactures surgical products and systems specifically for minimally invasive cardiac surgery.
BrioHealth Solutions develops medical technology for the treatment of advanced heart failure. The company's primary product is the BrioVAD system, an investigational Left Ventricular Assist System (LVAS) designed to improve the quality of life for heart failure patients.
Corvion Inc., formerly known as EverHeart Systems, is headquartered in Webster, Texas, and develops fully implanted mechanical circulatory support devices. Its flagship product, the Corvion LVAD, is designed to serve as a successful circulatory support device for severe heart failure.
Axon Therapies Inc. is a medical device and biotechnology company headquartered in Santa Clara, California, focused on developing treatments for heart failure.
V-Wave is a medical technology company established in Israel in 2009 that develops percutaneous implantable shunts and technologies for patients with chronic heart failure.
Micro Interventional Devices, Inc. is a medical equipment manufacturing company developing novel solutions for structural heart disease treatments like mitral valve repair.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.